{"id":"https://openalex.org/W3204735487","doi":"https://doi.org/10.1016/j.annonc.2021.08.1391","title":"1007P T-cells transgenic for a highly potent PRAME-specific TCR and a chimeric PD1-41BB co-stimulatory receptor represent a promising approach for the treatment of solid tumors","display_name":"1007P T-cells transgenic for a highly potent PRAME-specific TCR and a chimeric PD1-41BB co-stimulatory receptor represent a promising approach for the treatment of solid tumors","publication_year":2021,"publication_date":"2021-09-01","ids":{"openalex":"https://openalex.org/W3204735487","doi":"https://doi.org/10.1016/j.annonc.2021.08.1391","mag":"3204735487"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2021.08.1391","doi":"https://doi.org/10.1016/j.annonc.2021.08.1391","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.08.1391","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.annonc.2021.08.1391","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082770948","display_name":"Maja B\u00fcrdek","orcid":"https://orcid.org/0000-0002-1819-2122","observed_orcids":["https://orcid.org/0000-0002-1819-2122"]},"institutions":[{"id":"https://openalex.org/I122754167","display_name":"Medigene (Germany)","ror":"https://ror.org/03kkjyc12","country_code":"DE","type":"company","lineage":["https://openalex.org/I122754167"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. B\u00fcrdek","raw_affiliation_strings":["Translational Medicine, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany","institution_ids":["https://openalex.org/I122754167"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064697430","display_name":"Ina Fetzer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122754167","display_name":"Medigene (Germany)","ror":"https://ror.org/03kkjyc12","country_code":"DE","type":"company","lineage":["https://openalex.org/I122754167"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"I. Fetzer","raw_affiliation_strings":["Research & Development, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany","institution_ids":["https://openalex.org/I122754167"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050777980","display_name":"Nadja Sailer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122754167","display_name":"Medigene (Germany)","ror":"https://ror.org/03kkjyc12","country_code":"DE","type":"company","lineage":["https://openalex.org/I122754167"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"N. Sailer","raw_affiliation_strings":["Research & Development, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany","institution_ids":["https://openalex.org/I122754167"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023608201","display_name":"Melanie Salvermoser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122754167","display_name":"Medigene (Germany)","ror":"https://ror.org/03kkjyc12","country_code":"DE","type":"company","lineage":["https://openalex.org/I122754167"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. Salvermoser","raw_affiliation_strings":["Research & Development, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany","institution_ids":["https://openalex.org/I122754167"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056162886","display_name":"Doris Brechtefeld","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122754167","display_name":"Medigene (Germany)","ror":"https://ror.org/03kkjyc12","country_code":"DE","type":"company","lineage":["https://openalex.org/I122754167"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"D. Brechtefeld","raw_affiliation_strings":["Research & Development, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany","institution_ids":["https://openalex.org/I122754167"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042464438","display_name":"Kathrin Mutze","orcid":"https://orcid.org/0000-0002-5577-4500","observed_orcids":["https://orcid.org/0000-0002-5577-4500"]},"institutions":[{"id":"https://openalex.org/I122754167","display_name":"Medigene (Germany)","ror":"https://ror.org/03kkjyc12","country_code":"DE","type":"company","lineage":["https://openalex.org/I122754167"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"K. Mutze","raw_affiliation_strings":["Research & Development, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany","institution_ids":["https://openalex.org/I122754167"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113789458","display_name":"Silke H. Raffegerst","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122754167","display_name":"Medigene (Germany)","ror":"https://ror.org/03kkjyc12","country_code":"DE","type":"company","lineage":["https://openalex.org/I122754167"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"S. Raffegerst","raw_affiliation_strings":["Translational Medicine, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany","institution_ids":["https://openalex.org/I122754167"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002185322","display_name":"M. Braun","orcid":"https://orcid.org/0000-0003-2419-7816","observed_orcids":["https://orcid.org/0000-0003-2419-7816"]},"institutions":[{"id":"https://openalex.org/I122754167","display_name":"Medigene (Germany)","ror":"https://ror.org/03kkjyc12","country_code":"DE","type":"company","lineage":["https://openalex.org/I122754167"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. Braun","raw_affiliation_strings":["Research & Development, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany","institution_ids":["https://openalex.org/I122754167"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045802821","display_name":"Ren\u00e9 Goedkoop","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122754167","display_name":"Medigene (Germany)","ror":"https://ror.org/03kkjyc12","country_code":"DE","type":"company","lineage":["https://openalex.org/I122754167"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"R. Goedkoop","raw_affiliation_strings":["Clinical Affairs Department, Medigene AG, Planegg-Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Affairs Department, Medigene AG, Planegg-Martinsried, Germany","institution_ids":["https://openalex.org/I122754167"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016121613","display_name":"Susanne Wilde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122754167","display_name":"Medigene (Germany)","ror":"https://ror.org/03kkjyc12","country_code":"DE","type":"company","lineage":["https://openalex.org/I122754167"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"S. Wilde","raw_affiliation_strings":["Research & Development, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany","institution_ids":["https://openalex.org/I122754167"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027027069","display_name":"Daniel Sommermeyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122754167","display_name":"Medigene (Germany)","ror":"https://ror.org/03kkjyc12","country_code":"DE","type":"company","lineage":["https://openalex.org/I122754167"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"D. Sommermeyer","raw_affiliation_strings":["Research & Development, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany","institution_ids":["https://openalex.org/I122754167"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I122754167"],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.17571607,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":null,"first_page":"S851","last_page":"S852"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.033900000154972076,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.007899999618530273,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prame","display_name":"PRAME","score":0.8240000009536743},{"id":"https://openalex.org/keywords/t-cell-receptor-gene-therapy","display_name":"T cell receptor gene therapy","score":0.7009999752044678},{"id":"https://openalex.org/keywords/cancer-testis-antigens","display_name":"cancer-testis antigens","score":0.8169999718666077},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.6779999732971191},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.656000018119812},{"id":"https://openalex.org/keywords/pd-1-pd-l1-blockade","display_name":"PD-1/PD-L1 blockade","score":0.8690000176429749},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.699999988079071},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6539999842643738},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.574999988079071}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8382056951522827},{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.6836633086204529},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6191648244857788},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.6029260754585266},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.41662395000457764},{"id":"https://openalex.org/C102230213","wikidata":"https://www.wikidata.org/wiki/Q430117","display_name":"Transgene","level":3,"score":0.41517508029937744},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.256221204996109},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.2327713966369629},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21187016367912292},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.18827062845230103},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.12243238091468811},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09327560663223267},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0814996063709259},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07148352265357971}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2021.08.1391","doi":"https://doi.org/10.1016/j.annonc.2021.08.1391","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.08.1391","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2021.08.1391","doi":"https://doi.org/10.1016/j.annonc.2021.08.1391","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.08.1391","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4224119345","https://openalex.org/W3181940329","https://openalex.org/W3083665845","https://openalex.org/W3104873436","https://openalex.org/W4362593703","https://openalex.org/W4404005791","https://openalex.org/W4388048323","https://openalex.org/W2731585338","https://openalex.org/W4393095943","https://openalex.org/W4308398797"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2021-10-11T00:00:00"}